GBM induces reactive gliosis in surrounding brain tissues, which is characterized by morphological changes, increase in GFAP immunoreactivity and cellular distribution, besides the release of pro-inflammatory cytokines [22, 23]. This evidence concerns the gene GFAP and glioblastoma.